Human Phototoxicity Test (823/2016)
NCT02962856 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38
Last updated 2018-12-13
Summary
To determine the phototoxic potential of a topically applied article in human subjects
Conditions
- Sunscreening Agents
Interventions
- DRUG
-
BAY987517
50 μl/cm\*2 of each test product is applied to duplicate skin sites (approximately 2 x 2 cm each) on the lower or mid-back. (Formulation: Z43-078)
- OTHER
-
Untreated Skin
This site is patched without treatment as irradiated control
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-11-02
- Primary Completion
- 2016-11-05
- Completion
- 2016-11-05
Countries
- United States
Study Locations
More Related Trials
-
Test the Outdoor Usage for Sunscreen Products in Female Adults
NCT02779270 ·Status: COMPLETED ·Phase: NA
-
Phototoxicity of Frequently Prescribed Medicines
NCT06710600 ·Status: COMPLETED ·Phase: NA
-
Dermal Phototoxicity Study
NCT04070742 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic (PK) Evaluation of Bemotrizinol (6%) in a Sunscreen Maximum Usage Trial
NCT05277376 ·Status: COMPLETED ·Phase: PHASE3
-
A Single-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-986263 in Participants With Varying Degrees of Liver Impairment
NCT04225936 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety and Pharmacokinetics of HBI-002, an Oral Carbon Monoxide Therapeutic, in Healthy Volunteers
NCT03926819 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Drug Levels, Physical and Chemical Changes, and Removal of BMS-986196 in Healthy Male Participants
NCT05981963 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Determine the Pharmacokinetics, Pharmacodynamics, and Tolerabiltiy of Betrixaban in Patients With Mild, Moderate, and Severe Renal Impairment
NCT00999336 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics Study of Multiple Ascending Doses of BTA-C585 in Healthy Volunteers
NCT02668367 ·Status: COMPLETED ·Phase: PHASE1
-
Single-dose Pharmacokinetics of BMS-986177 in Participants With Hepatic Impairment Compared to Healthy Participants
NCT02982707 ·Status: COMPLETED ·Phase: PHASE1
-
Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA)
NCT00983255 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment
NCT04634149 ·Status: COMPLETED ·Phase: PHASE1
-
An Open Label Study to Assess the Effect of BLI800 on Safety and Clinical Chemistry Parameters
NCT00583713 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pharmacokinetic Study of ABT-126 in Healthy Volunteers
NCT00959634 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ABT-436 in Healthy Adults
NCT01050127 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of Stiripentol and Its Metabolites After Multiple Dose Oral Administration in Healthy Male Volunteers
NCT03866928 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment
NCT07248839 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Dose-Finding of Retinoid 9cUAB30 in Healthy Volunteers
NCT01336387 ·Status: TERMINATED ·Phase: PHASE1
-
A Bioavailability and Pharmacokinetic Study of GDC-0032 in Healthy Volunteers
NCT01967966 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions
NCT03603106 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study in Healthy Men to Test How BI 1291583 is Processed in the Body
NCT05833035 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction
NCT01708889 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293
NCT02126514 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone in Volunteers With Impaired Hepatic Function
NCT01367522 ·Status: COMPLETED ·Phase: PHASE1
-
Ultra Violet B Radiation (UVR) Study of Strontium Chloride Hexahydrate Hydrocortisone
NCT01301677 ·Status: COMPLETED ·Phase: PHASE1